CPOCX
Price
$19.27
Change
+$0.47 (+2.50%)
Updated
Dec 3 closing price
Net Assets
1.46B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

CPOCX vs VIGRX

Header iconCPOCX vs VIGRX Comparison
Open Charts CPOCX vs VIGRXBanner chart's image
Morgan Stanley Insight L
Price$19.27
Change+$0.47 (+2.50%)
VolumeN/A
Net Assets1.46B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
CPOCX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
CPOCX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPOCX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. CPOCX (1.46B). CPOCX pays higher dividends than VIGRX: CPOCX (1.31) vs VIGRX (0.30). CPOCX was incepted earlier than VIGRX: CPOCX (28 years) vs VIGRX (33 years). CPOCX (1.64) is less costly to investors than VIGRX (0.17). CPOCX is a more actively managed with annual turnover of: 44.00 vs. VIGRX (11.00). CPOCX has a lower initial minimum investment than VIGRX: CPOCX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. CPOCX (17.05). VIGRX return over 5 years is better than : 99.11 vs. CPOCX (-67.66).
CPOCXVIGRXCPOCX / VIGRX
Total Expense Ratio1.640.17965%
Annual Report Gross Expense Ratio1.640.17965%
Fund Existence28 years33 years-
Gain YTD22.27219.764113%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B357B0%
Annual Yield % from dividends1.310.30430%
Returns for 1 year17.0518.4992%
Returns for 3 years11.38110.8210%
Returns for 5 years-67.6699.11-68%
Returns for 10 years-34.12349.13-10%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT